Solange Peters
机构：Inserm, Université de Lille, Centre Hospitalier Universitaire Vaudois, Centre Hospitalier Universitaire de Lille, Centre de Recherche en Cancérologie de Lyon, Onco Lille, CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers, University of Lausanne
发表论文 930 篇 · 总被引 72576 次 · h-index 114
代表论文
- Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis (2025 · The Lancet Oncology · 被引 43)
- Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study (2025 · Annals of Oncology · 被引 19)
- Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma (2025 · Annals of Oncology · 被引 8)
- OA08.02 Efficacy and Safety of 1L Olomorasib + Chemoimmunotherapy in KRAS G12C-Mutant NSCLC: Results From LOXO-RAS-20001 and SUNRAY-01 (2025 · Journal of Thoracic Oncology · 被引 4)
- Promoting equitable access to financial services to end financial discrimination against cancer survivors in Europe: scientific and ethical reasons (2025 · ESMO Open · 被引 3)
- Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study (2026 · The Lancet Oncology · 被引 1)